Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)

Author： Koinis Filippos   Polyzos Aristidis   Christopoulou Athina   Zafeiriou Zafeiris   Emmanouilidis Christos   Papadimitraki Elisavet   Kalykaki Antonia   Kalbakis Kostas   Samonis George   Georgoulias Vassilis  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.73, Iss.4, 2014-04, pp. : 819-825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Phase II Study of Paclitaxel in Platinum Pretreated Ovarian Cancer. A Hellenic Cooperative Oncology Group Study

By Aravantinos G.   Skarlos D.V.   Kosmidis P.   Athanassiades A.   Bafaloukos D.   Giannakakis T.   Karpathios S.   Fountzilas G.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 160-163

Elsevier

Access to resources Recommend Favorite

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

By Ulrich-Pur Herbert   Kornek Gabriela   Haider Karin   Kwasny Werner   Payrits Thomas   Dworan Nina   Vormittag Laurenz   Depisch Dieter   Lang Fritz   Scheithauer Werner  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 208-213

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel in Recurrent Ovarian Cancer: Better Upfront? Comments On: A Phase II Study of Paclitaxel in Platinum Pretreated Ovarian Cancer. A Hellenic Cooperative Oncology Group Study

By Bulusu V.R.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1905-1906

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Pyrazoloacridine in Recurrent Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

By Plaxe S.C.   Blessing J.A.   Bookman M.A.   Creasman W.T.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 32-35

Elsevier

Access to resources Recommend Favorite

Phase II study of pegylated liposomal doxorubicin (Caelyx&unknown;) as induction chemotherapy for patients with squamous cell cancer of the head and neck

By Harrington K.J.   Lewanski C.   Northcote A.D.   Whittaker J.   Peters A.M.   Vile R.G.   Stewart J.S.W.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2015-2022

Elsevier

Access to resources Recommend Favorite